Stockreport

https://seekingalpha.com/article/4764992-aldeyra-therapeutics-is-severely-undervalued-before-pdufa [Seeking Alpha]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF Despite a controversial deal with AbbVie, Aldeyra remains financially solid, with $100M in cash and potential milestone payments. The DED market is strong, and reprox [Read more]